Serum peptides as candidate biomarkers for dementia with Lewy bodiesItsuku Suzuki, Manae S. Kurokawa, Miwa Noguchi et al.|International Journal of Geriatric Psychiatry|2015Cited by 15
The relationship between the daily dose, the plasma concentration of AD-5423 (blonanserin), and its plasma anti-dopamine (D2) and anti-serotonin (5-HT2A) activity, and the plasma serotonin/dopamine (S/D) ratioHidenobu Suzuki, A. Aoba, Y. Morokawa et al.|International Clinical Psychopharmacology|2003Cited by 1
EFFECTS OF BROMOCRIPTINE IN HUNTINGTON CHOREAT. Tsuneizumi, Kanae Hasegawa, M. Kamimura et al.|Clinical Neuropharmacology|1992Cited by 1
THE EFFECT OF AGE ON PLASMA LEVEL OF SETIPTILINE MALEATE IN DEPRESSED PATIENTS.M. Kaminura, K Hasegawa, A. Aoba et al.|Clinical Neuropharmacology|1992Cited by 0